A detailed history of Quest Partners LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 8 shares of AXNX stock, worth $563. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 32,176 99.98%
Holding current value
$563
Previous $2.16 Billion 99.97%
% of portfolio
0.0%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$67.3 - $69.67 $2.16 Million - $2.24 Million
-32,168 Reduced 99.98%
8 $557,000
Q2 2024

Aug 06, 2024

BUY
$66.47 - $69.65 $2.14 Million - $2.24 Million
32,176 New
32,176 $2.16 Billion

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.46B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.